Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Papajík

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Vnitrni Lekarstvi|November 1, 1993
[Alport's syndrome]T Papajík, J Zadrazil, P Bachleda
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1994
[Erythrocytosis after kidney transplantation]J Zadrazil, P Bachleda, T Papajík, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1994
[The so-called "complicated AV-fistula" for hemodialysis. Contribution to preoperative examinations]P Bachleda, J Zadrazil, M Köcher, et al.
Vnitrni Lekarstvi|June 14, 2002
[Therapeutic effectiveness of cladribine and cellular immunodeficiency--related effects in hairy-cell leukemia?]L Raida, T Papajík, Z Pikalová, et al.
Vnitrni Lekarstvi|March 1, 1994
[Serum thymidine kinase in multiple myeloma: I. Relation to selected laboratory indicators in the disease]V Scudla, J Bacovský, T Papajík, et al.
Vnitrni Lekarstvi|March 1, 1994
[Serum thymidine kinase in multiple myeloma: II. Relation to disease activity and stage]V Scudla, T Papajík, J Bacovský, et al.
Vnitrni Lekarstvi|August 1, 1993
[Treatment of resistant forms of multiple myeloma using a combination of mitoxantrone, vincristine and prednisone (the NOP regimen)]V Scudla, J Bacovský, L Faltýnek, et al.
Vnitrni Lekarstvi|August 1, 1994
[Clinical importance of the paraprotein index in multiple myeloma]T Papajík, J Bacovský, J Zadrazil, et al.
Vnitrni Lekarstvi|April 1, 1991
[The iron reserve status in patients on regular dialysis treatment]J Zadrazil, T Papajík, V Scudla, et al.
Vnitrni Lekarstvi|June 1, 1994
[The role of iron deficiency on the development of anemia in patients on regular dialysis therapy]J Zadrazil, T Papajík, P Bachleda, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Vnitrni Lekarstvi|November 1, 1993
[Alport's syndrome]T Papajík, J Zadrazil, P Bachleda
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1994
[Erythrocytosis after kidney transplantation]J Zadrazil, P Bachleda, T Papajík, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1994
[The so-called "complicated AV-fistula" for hemodialysis. Contribution to preoperative examinations]P Bachleda, J Zadrazil, M Köcher, et al.
Vnitrni Lekarstvi|June 14, 2002
[Therapeutic effectiveness of cladribine and cellular immunodeficiency--related effects in hairy-cell leukemia?]L Raida, T Papajík, Z Pikalová, et al.
Vnitrni Lekarstvi|March 1, 1994
[Serum thymidine kinase in multiple myeloma: I. Relation to selected laboratory indicators in the disease]V Scudla, J Bacovský, T Papajík, et al.
Vnitrni Lekarstvi|March 1, 1994
[Serum thymidine kinase in multiple myeloma: II. Relation to disease activity and stage]V Scudla, T Papajík, J Bacovský, et al.
Vnitrni Lekarstvi|August 1, 1993
[Treatment of resistant forms of multiple myeloma using a combination of mitoxantrone, vincristine and prednisone (the NOP regimen)]V Scudla, J Bacovský, L Faltýnek, et al.
Vnitrni Lekarstvi|August 1, 1994
[Clinical importance of the paraprotein index in multiple myeloma]T Papajík, J Bacovský, J Zadrazil, et al.
Vnitrni Lekarstvi|April 1, 1991
[The iron reserve status in patients on regular dialysis treatment]J Zadrazil, T Papajík, V Scudla, et al.
Vnitrni Lekarstvi|June 1, 1994
[The role of iron deficiency on the development of anemia in patients on regular dialysis therapy]J Zadrazil, T Papajík, P Bachleda, et al.
Pageof 3